Search research articles
Contact Us
Filters
Showing results (691-700 of 962) with videos related to
Page
of 97
Sort By:
Nature Reviews. Cardiology
|
July 6, 2018
Aspirin-free strategies in cardiovascular disease and cardioembolic stroke prevention
Davide Capodanno, Roxana Mehran, Marco Valgimigli, et al.
Circulation
|
November 12, 2019
REDUCE-IT USA: Results From the 3146 Patients Randomized in the United States
Deepak L Bhatt, Michael Miller, Eliot A Brinton, et al.
The New England Journal of Medicine
|
September 3, 2013
Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus
Benjamin M Scirica, Deepak L Bhatt, Eugene Braunwald, et al.
European Heart Journal
|
November 30, 2017
External applicability of the COMPASS trial: an analysis of the reduction of atherothrombosis for continued health (REACH) registry
Arthur Darmon, Deepak L Bhatt, Yedid Elbez, et al.
JAMA
|
February 9, 2021
Effect of a Restrictive vs Liberal Blood Transfusion Strategy on Major Cardiovascular Events Among Patients With Acute Myocardial Infarction and Anemia: The REALITY Randomized Clinical Trial
Gregory Ducrocq, Jose R Gonzalez-Juanatey, Etienne Puymirat, et al.
International Journal of Cardiology
|
June 26, 2018
Definitions of peri-procedural myocardial infarction and the association with one-year mortality: Insights from CHAMPION trials
Christoph B Olivier, Vandana Sundaram, Deepak L Bhatt, et al.
Journal of the American College of Cardiology
|
April 24, 2024
Limb Outcomes With Ticagrelor Plus Aspirin in Patients With Diabetes Mellitus and Atherosclerosis
Marc P Bonaca, Deepak L Bhatt, Tabassome Simon, et al.
JAMA
|
September 3, 2009
Immediate vs delayed intervention for acute coronary syndromes: a randomized clinical trial
Gilles Montalescot, Guillaume Cayla, Jean-Philippe Collet, et al.
The American Journal of Medicine
|
May 12, 2020
Comparison of Dabigatran Plus a P2Y<sub>12</sub> Inhibitor With Warfarin-Based Triple Therapy Across Body Mass Index in RE-DUAL PCI
Raffaele De Caterina, Antonio Procopio, José-Luis Lopez Sendon, et al.
Circulation
|
March 23, 2005
Randomized, blinded trial comparing fondaparinux with unfractionated heparin in patients undergoing contemporary percutaneous coronary intervention: Arixtra Study in Percutaneous Coronary Intervention: a Randomized Evaluation (ASPIRE) Pilot Trial
Shamir R Mehta, Philippe Gabriel Steg, Christopher B Granger, et al.
Page
of 97
Search research articles
Search
Showing results (691-700 of 962) with videos related to
Sort By:
Page
of 97
Nature Reviews. Cardiology
|
July 6, 2018
Aspirin-free strategies in cardiovascular disease and cardioembolic stroke prevention
Davide Capodanno, Roxana Mehran, Marco Valgimigli, et al.
Circulation
|
November 12, 2019
REDUCE-IT USA: Results From the 3146 Patients Randomized in the United States
Deepak L Bhatt, Michael Miller, Eliot A Brinton, et al.
The New England Journal of Medicine
|
September 3, 2013
Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus
Benjamin M Scirica, Deepak L Bhatt, Eugene Braunwald, et al.
European Heart Journal
|
November 30, 2017
External applicability of the COMPASS trial: an analysis of the reduction of atherothrombosis for continued health (REACH) registry
Arthur Darmon, Deepak L Bhatt, Yedid Elbez, et al.
JAMA
|
February 9, 2021
Effect of a Restrictive vs Liberal Blood Transfusion Strategy on Major Cardiovascular Events Among Patients With Acute Myocardial Infarction and Anemia: The REALITY Randomized Clinical Trial
Gregory Ducrocq, Jose R Gonzalez-Juanatey, Etienne Puymirat, et al.
International Journal of Cardiology
|
June 26, 2018
Definitions of peri-procedural myocardial infarction and the association with one-year mortality: Insights from CHAMPION trials
Christoph B Olivier, Vandana Sundaram, Deepak L Bhatt, et al.
Journal of the American College of Cardiology
|
April 24, 2024
Limb Outcomes With Ticagrelor Plus Aspirin in Patients With Diabetes Mellitus and Atherosclerosis
Marc P Bonaca, Deepak L Bhatt, Tabassome Simon, et al.
JAMA
|
September 3, 2009
Immediate vs delayed intervention for acute coronary syndromes: a randomized clinical trial
Gilles Montalescot, Guillaume Cayla, Jean-Philippe Collet, et al.
The American Journal of Medicine
|
May 12, 2020
Comparison of Dabigatran Plus a P2Y<sub>12</sub> Inhibitor With Warfarin-Based Triple Therapy Across Body Mass Index in RE-DUAL PCI
Raffaele De Caterina, Antonio Procopio, José-Luis Lopez Sendon, et al.
Circulation
|
March 23, 2005
Randomized, blinded trial comparing fondaparinux with unfractionated heparin in patients undergoing contemporary percutaneous coronary intervention: Arixtra Study in Percutaneous Coronary Intervention: a Randomized Evaluation (ASPIRE) Pilot Trial
Shamir R Mehta, Philippe Gabriel Steg, Christopher B Granger, et al.
Page
of 97